Drugs / Lu AG06474
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06077786 | Oct 2023 → May 2024 | — | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 1 | NCT05943327 | Jun 2023 → Jul 2024 | — | H. Lundbeck A/S | Terminated | No outcome recorded Stop: Business |
| Phase 1 | NCT05003687 | Aug 2021 → Dec 2022 | — | H. Lundbeck A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lu AG06474 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06077786 ↗ |
| Route | Oral | “solution, orally (Parts A and B)” NCT05003687 ↗ |